PTCT insider trading
Ptc Therapeutics, Inc.
In the past 36 days, 3 insiders sold $3.8M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Mark Elliott Boulding EXEC. VP AND CLO |
$12K 192 sh @ $64.26 |
−0.2% | Pre-scheduled | Oct 9, 2026 Filed Oct 13, 2026 |
Michael Schmertzler Director |
$158K 2,500 sh @ $63.39 |
−0.2% | Pre-scheduled | Oct 7, 2026 Filed Oct 9, 2026 |
Mark Elliott Boulding EXEC. VP AND CLO |
$133K 2,073 sh @ $64.06 |
−1.9% | Pre-scheduled | Oct 5, 2026 Filed Oct 7, 2026 |
Glenn Jr Md Phd Steele Director |
$782K 12,000 sh @ $65.16 |
−34.8% | Pre-scheduled | Sep 30, 2026 Filed Oct 2, 2026 |
Michael Schmertzler Director |
$1.3M 20,000 sh @ $67.49 |
−1.5% | Pre-scheduled | Sep 16, 2026 Filed Sep 18, 2026 |
Michael Schmertzler Director |
$1.4M 20,000 sh @ $67.59 |
−1.5% | Pre-scheduled | Sep 9, 2026 Filed Sep 11, 2026 |